瞼板腺功能障礙的治療劑

• 收藏
• 分享

专利权人:

SANTEN PHARMACEUTICAL CO., LTD.;參天製藥株式會社

发明人:

Hideki MIYAKE,Tomoko ODA,Daisuke SHII,小田知子,Daisuke SHII,椎大介

申请号：

HK18105546.8

公开号：

HK1245680A

申请日:

2016.05.14

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

A compound represented by the formula (1): wherein R 1 represents a hydroxyl group, a dimethylphosphynoyloxy group, etc.； and R 2 and R 3 represent a methoxy group, etc., or a pharmaceutically acceptable salt thereof can reduce a score of telangiectasia around the meibomian gland orifices and a number of obstruction at the orifices, so that it is useful as a prophylactic and/or therapeutic agent for meibomian gland dysfunction.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/